What’s new in the renin-angiotensin system?Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus

被引:0
作者
J. H. Kuhn
W. Li
H. Choe
M. Farzan
机构
[1] Harvard Medical School,Partners AIDS Research Center, Brigham and Women’s Hospital, Department of Medicine (Microbiology and Molecular Genetics)
[2] Harvard Medical School,Perlmutter Laboratory, Pulmonary Division, Children’s Hospital, Department of Pediatrics
[3] Harvard Medical School,Partners AIDS Research Center, Brigham and Women’s Hospital, Department of Medicine (Microbiology and Molecular Genetics)
[4] Freie Universität Berlin,Department of Biology, Chemistry, Pharmacy
来源
Cellular and Molecular Life Sciences CMLS | 2004年 / 61卷
关键词
Severe acute respiratory syndrome; SARS; coronavirus; angiotensin-converting enzyme 2; ACE2; viral fusion;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular entry of enveloped viruses is often dependent on attachment proteins expressed on the host cell surface. Viral envelope proteins bind these receptors, and, in an incompletely understood process, facilitate fusion of the cellular and viral membranes so as to introduce the viral core into the cytoplasm. Only a small fraction of viral receptors have been identified so far. Recently, a novel coronavirus was identified as the etiological agent of severe acute respiratory syndrome (SARS). The fusion protein gene of SARS coronavirus (SARS-CoV) was cloned and characterized, and shortly thereafter, angiotensin-converting enzyme 2 (ACE2) was shown to be its functional receptor. Identification of ACE2 as a receptor for SARS-CoV will likely contribute to the development of antivirals and vaccines. It may also contribute to the development of additional animal models for studying SARS pathogenesis, and could help identify the animal reservoir of SARS-CoV.
引用
收藏
页码:2738 / 2743
页数:5
相关论文
共 50 条
  • [1] Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
    Kuhn, JH
    Li, W
    Choe, H
    Farzan, M
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2738 - 2743
  • [2] Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system
    Lambert, Daniel W.
    Hooper, Nigel M.
    Turner, Anthony J.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (04) : 781 - 786
  • [3] Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
    Edmonston, Daniel L.
    South, Andrew M.
    Sparks, Matthew A.
    Cohen, Jordana B.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (05) : 404 - 411
  • [4] What’s new in the renin-angiotensin system?Angiotensin-converting enzyme-2: a molecular and cellular perspective
    F. J. Warner
    A. I. Smith
    N. M. Hooper
    A. J. Turner
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 2704 - 2713
  • [5] SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
    Felber, Randy
    New, William
    Riskin, Suzanne I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [6] Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
    Santos, Robson A. S.
    Ferreira, Anderson J.
    Verano-Braga, Thiago
    Bader, Michael
    JOURNAL OF ENDOCRINOLOGY, 2013, 216 (02) : R1 - R17
  • [7] The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
    Ferrara, Francesco
    Vitiello, Antonio
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (07) : 1589 - 1593
  • [8] Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease
    Tikellis, Chris
    Bernardi, Stella
    Burns, Wendy C.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (01) : 62 - 68
  • [9] Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus
    Cano, F.
    Gajardo, M.
    Freundlich, M.
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2020, 91 (03): : 330 - 338
  • [10] Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy
    Oudit G.Y.
    Penninger J.M.
    Current Heart Failure Reports, 2011, 8 (3) : 176 - 183